Table 5 Summary of third aim.
Author | SAA(°) | Pre AHD (mm) | Post AHD (mm) | p value | Change | Outcome measures | Pre pain/disability | Post pain/disabilty | p value | Change |
|---|---|---|---|---|---|---|---|---|---|---|
Akkaya et al.59 (n = 34) | 0 | 11.20 ± 2.30 | 11.10 ± 2.00 | p = 0.887 | ↔ | SPADI | 62.0 ± 21.5 | 32.4 ± 18.7 | p = 0.001 | ↑ |
30 | 10.50 ± 1.90 | 10.60 ± 1.90 | p = 0.257 | ↔ | ||||||
VAS | 2.4 ± 2.1 | 0.9 ± 1.2 | p = 0.006 | ↑ | ||||||
60 | 10.30 ± 1.90 | 10.50 ± 2.20 | p = 0.571 | ↔ | ||||||
Belley et al.60 (n = 40) | 0 | 10.80 ± 1.70 | 11.00 ± 1.40 | p > 0.05 | ↔ | DASH | 33.0 ± 13.6 | 9.5 ± 9.6 | p < 0.05 | ↑ |
45 | 8.90 ± 1.40 | 9.50 ± 1.50 | p < 0.05 | ↑! | ||||||
WORC% | 53.8 ± 18.1% | 89.7 ± 12.5% | p < 0.05 | ↑ | ||||||
60 | 8.60 ± 1.40 | 9.30 ± 1.50 | p < 0.05 | ↑! | ||||||
Boudreau et al.61 (n = 42) | 0 | 10.8 ± 2.1 | 11.5 ± 2.7 | p = 0.56 | ↔ | DASH | 32.2 ± 15.4 | 27.8 ± 18.7 | p > 0.211 | ↑ |
30 | 10.4 ± 2.3 | 10.6 ± 2.4 | p = 0.44 | ↔ | WORC% | 51.6 ± 18.5% | 65.7 ± 25.8% | p < 0.001 | ↑ | |
60 | 9.5 ± 2.7 | 9.8 ± 2.4 | p = 0.75# | ↔ | VAS | 71.1 ± 17.3 | 56.1 ± 29.6 | p < 0.001 | ↑ | |
Dupuis et al.62 (n = 43) | 0 | 10 ± 2 | 10 ± 1 | p > 0.11 | ↔ | DASH | 29.3 ± 12.6 | 16.3 ± 11.3 | p < 0.05 | ↑ |
45 | 8 ± 2 | 8 ± 2 | p > 0.11 | ↔ | ||||||
WORC% | 55.7 ± 21.0% | 80.6 ± 17.1% | p < 0.05 | ↑ | ||||||
60 | 7 ± 2 | 7 ± 2 | p > 0.11 | ↔ | ||||||
Desmeules et al.32 (n = 20) | Correlation between max change in AHD (0°–60°) and improvements in WORC % score (r = 0.86, p = 0.01) | |||||||||
Savoie et al.29 (n = 45) | 0 | 9.9 ± 2.0 | 10.4 ± 1.7 | p > 0.05 | ↔ | DASH | Change in DASH score: 17.1 ± 12.4 | p < 0.001 | ↑ | |
45 | 7.9 ± 2.2 | 8.8 ± 1.6 | p < 0.05 | ↑! | WORC% | Change in WORC%score: −30.1 ± 14.0% | p < 0.001 | ↑ | ||
60 | 7.5 ± 2.1 | 8.2 ± 1.7 | p < 0.05 | ↑! | ||||||